Log into your Newser account
Joined Newser on:
Find what you're looking for
More about Newser:
Want to contribute?
Suggest a Story
Get our apps:
Install our app:
Stories 1 - 20 |
2 More Conglomerates
Are Breaking Up
Nov 12, 2021 9:43 AM CST
2 More Conglomerates Are Breaking Up
J&J, Toshiba announce plans to separate their businesses in coming years
- Johnson & Johnson plans to split into two publicly traded companies. And in case you're wondering, no, they won't be called "Johnson I" and "Johnson II." Johnson & Johnson will keep its name and its title as the world's largest health-products company by sales...
Deaths Spike as
OD Antidote Price Soars
Oct 20, 2021 7:29 AM CDT
Deaths Spike as OD Antidote Price Soars
Expert attributes thousands of deaths to greed amid naxolone supply issues
- The US has seen a record high in overdose deaths during the pandemic, and an addiction expert says "we can expect even more fatal overdoses" now that a medication that reverses overdoses has jumped up to 30 times in price. The Opioid Safety and Naloxone Network Buyers Club, a...
Merck's COVID Pill Trial Went
So Well It Was Halted Early
Oct 1, 2021 7:54 AM CDT
Merck's COVID Pill Trial Went So Well It Was Halted Early
Emergency use authorization could be next for antiviral drug molnupiravir after positive results
- The makers of what could be the first antiviral pill for COVID-19 said Friday that they will request emergency use authorization in the US as soon as possible. An independent board of experts monitoring the clinical trial of molnupiravir from drug-maker Merck and Ridgeback Biotherapeutics recommended it be halted early...
Johnson & Johnson Settles For
$230M, Quits Opioid Business
Jun 26, 2021 3:30 PM CDT
Johnson & Johnson Settles For $230M, Quits Opioid Business
Deal takes the pharmaceutical giant out of huge New York trial
- Johnson & Johnson is going out of the opioid business in the US. It's also going to pay the state of New York a $230 million settlement, the
New York Times
reports. The agreement takes them out of a trial of several pharmaceutical makers slated to start next week....
Jun 24, 2020 2:20 PM CDT
Bayer: We'll Settle Suit With $10.9B Payment
The German company faces a lawsuit that involves subsidiary Monsanto
- German pharmaceutical company Bayer says it's paying up to $10.9 billion to settle a lawsuit over subsidiary Monsanto’s weedkiller Roundup, which has faced numerous lawsuits over claims it causes cancer, the AP reports. In a statement Wednesday, Bayer said it was also paying up $1.22 billion...
Shkreli Once Again in
Hot Water Over Pricey Drug
Jan 28, 2020 3:09 PM CST
Shkreli Once Again in Hot Water Over Pricey Drug
'Pharma Bro' sued by FTC, New York AG over Daraprim
- Martin Shkreli's original controversy is back in the headlines. The disgraced CEO of Turing Pharmaceuticals first gained infamy back in 2015 when his company jacked the price of Daraprim, a lifesaving drug that treats the parasitic infection toxoplasmosis, by 5,000%. Then he went to prison over an unrelated...
State Sues Walgreens,
3 Other Firms Under
Drug Dealer Law
Dec 18, 2019 2:07 AM CST
State Sues Walgreens, 3 Other Firms Under Drug Dealer Law
'They knowingly and deliberately distributed drugs in our state without controls'
- Michigan on Tuesday sued four companies over the deadly painkiller epidemic, becoming what state Attorney General Dana Nessel says is the first state to sue major opioid distributors under a liability law that is typically used to go after drug dealers. The lawsuit was filed in Wayne County and names...
FDA: Data Manipulated Before
Approval of $2.1M Drug
Aug 7, 2019 2:38 AM CDT
FDA: Data Manipulated Before Approval of $2.1M Drug
Novartis could face civil, criminal penalties
- US regulators want to know why Novartis didn't disclose a problem with testing data until after the Swiss drugmaker's $2.1 million gene therapy was approved. The Food and Drug Administration said Tuesday the manipulated data involved testing in animals, not patients, and it's confident that the...
Trump Administration Makes
Big Move on Pharmaceuticals
Jul 31, 2019 10:00 AM CDT
Trump Administration Makes Big Move on Pharmaceuticals
Americans will be allowed to import lower-cost prescription drugs from Canada
- The Trump administration said Wednesday it will set up a system to allow Americans to legally import lower-cost prescription drugs from Canada, weakening a long-standing ban that had stood as a top priority for the politically powerful pharmaceutical industry. Health and Human Services Secretary Alex Azar made the announcement Wednesday...
A Tweak to TV Ads for
Prescription Drugs Is Coming
May 8, 2019 12:38 PM CDT
A Tweak to TV Ads for Prescription Drugs Is Coming
Prices will have to be included
- Those ever-present TV ads for prescription drugs will soon reveal prices, too, the nation's top health official said Wednesday, responding to a public outcry for government action to restrain medication costs. Health and Human Services Secretary Alex Azar said the Trump administration has finalized regulations that will require drug...
May 2, 2019 4:49 PM CDT
Pharma Exec Convicted in Sensational Opioid Case
John Kapoor's Insys Therapeutics used illegal tactics to sell its fentanyl spray
- A pharmaceutical company founder accused of paying doctors millions in bribes to prescribe a highly addictive fentanyl spray was convicted Thursday in a case that exposed such marketing tactics as using a stripper-turned-sales-rep to give a physician a lap dance. John Kapoor, the 76-year-old former chairman of Insys Therapeutics, was...
Professor Accused of Selling
Student's Research for $1.5M
Feb 28, 2019 3:57 AM CST
Professor Accused of Selling Student's Research for $1.5M
University of Missouri is suing pharmacy professor
- The University of Missouri system is suing a pharmacy professor at its Kansas City campus over allegations he stole and sold a student's research, claiming that the school is the rightful owner of work it believes could be used to make a billion-dollar drug. The university has filed a...
to Know Why Drug
Went From Free
Feb 4, 2019 5:50 PM CST
Sanders Demands to Know Why Drug Went From Free to $375K
The medication, Firdapse, treats a rare neuromuscular disease
- Calling it corporate greed, Bernie Sanders wants a pharmaceutical company's justification for why it charges $375,000 per year for a drug that used to be free. "I am profoundly concerned that Catalyst's actions will cause patients to suffer or die," the Vermont senator and possible...
Pharma Exec on 400% Drug
Price Jump: 'Moral Requirement'
Sep 12, 2018 12:33 AM CDT
Pharma Exec on 400% Drug Price Jump: 'Moral Requirement'
Nirmal Mulye defends move, says he's in the drug business 'to make money'
- The founder and president of a pharmaceutical company that last month raised the price of an "essential" antibiotic from $474.75 per bottle to $2,392 per bottle tells the
the 400% increase was not only justifiable but morally imperative. "I think it is a moral...
Trump Tweeted Pfizer Should
Be 'Ashamed.' Pfizer Responds
Jul 11, 2018 8:22 AM CDT
Trump Tweeted Pfizer Should Be 'Ashamed.' Pfizer Responds
After meeting between Trump and Pfizer CEO Ian Read, company says it will defer price hikes
- Last week, Pfizer jacked up the price for several dozen prescription drugs; this week it received a dressing down from President Trump. Now, per the
Wall Street Journal
, the pharmaceuticals giant has responded to his criticism with a postponement on those price hikes after the company said CEO Ian Read...
Company Sold $1.3B of a Drug
That's Not Hugely Effective
Jun 25, 2018 8:41 AM CDT
Company Sold $1.3B of a Drug That's Not Hugely Effective
Inside New York state's pushback against Orkambi
- Only 28,000 of the planet's 7 billion people are eligible to take the cystic fibrosis drug Orkambi. And yet that tiny population enabled drugmaker Vertex to make roughly $1.3 billion in sales off the product. How does that math work out? The annual price of the drug...
'Pharma Bro' Faces
Mar 9, 2018 12:19 AM CST
'Pharma Bro' Faces High-Stakes Sentencing
Prosecutors want Shkreli to get 15 years
- Is "Pharma Bro" Martin Shkreli a master manipulator who conned wealthy investors or a misunderstood eccentric who used unconventional means to make those same investors even wealthier? A federal judge in Brooklyn will have to weigh the conflicting portrayals of the former pharmaceutical company CEO on Friday at his...
Search for Alzheimer's
Treatment Is Dealt a Blow
Jan 8, 2018 10:40 AM CST
Search for Alzheimer's Treatment Is Dealt a Blow
Pfizer announced R&D on new drugs will cease
- The Alzheimer's Association estimates that more than 5 million Americans are living with the disease—and that by 2050, that count could triple. But Pfizer on Saturday announced it's getting out of the Alzheimer's game, at least when it comes to researching potential new drugs. The company...
Will Cost $850K
Jan 4, 2018 11:40 AM CST
Company Says Its Treatment for Blindness Will Cost $850K
Spark Therapeutics reveals Luxturna gene therapy will cost $425K per eye
- It's a gradual and cruel fate: an inherited form of vision loss that typically ends in blindness and has had no cure. But for those with mutations in a gene known as RPE65 comes a balm. The FDA in December approved Luxturna, a new gene therapy that can treat...
Lawyer Guilty of Helping
Shkreli Cover Up Fraud
Dec 28, 2017 12:46 AM CST
Lawyer Guilty of Helping Shkreli Cover Up Fraud
Verdict sends a powerful message, prosecutor says
- A lawyer accused of helping Martin Shkreli cover up financial fraud was convicted on Wednesday, a result a prosecutor said should send a "powerful message" through the legal profession. After an 11-week trial, Evan Greebel was convicted by a federal jury in Brooklyn of conspiring to commit securities fraud...
Stories 1 - 20 |
Popular on Newser
After 24-Hour Treatment, Frogs Started Regrowing Lost Limbs
After Bridge Collapses, a Human Chain Forms
Retrieval of Sunken F35 Is 'Vitally Important' for US
Buffalo Bills Have Fans Arrested Over Their Vaccine Cards
Michael Madsen: Son's Death Is 'Mind-Blowing'
On This Day:
10 Years of Headlines
We see that you're using an ad-blocker.
To read our stories, you'll need to
turn off your ad-blocker.
As an advertising-supported site,
Newser can't exist without ads.
Turn off your ad-blocker
(for Newser only)
One last step.
You have to do this part yourself.
But you're a smartie, and we'll help you out.
1. Click on your ad-blocker icon in your browser.
(It might look like this
2. Every ad-blocker is a bit different, but look for
an option like disable, whitelist, or trust and click it.
Thanks so much.